NIH Director EXCLUSIVE: Social Media Ban, Over-Prescription & Saving Gen Z
What this video covers
A long podcast interview in which 21-year-old host Elliot Bewick presses Bhattacharya on social media’s effects on Gen Z, then — disclosing a personal stake, since his girlfriend lives with post-SSRI sexual dysfunction — pushes him hard on antidepressant over-prescription, weak evidence, and long-term side effects.
Key points
- Asked whether he would support a social media ban for under-16s, Bhattacharya says the age cutoff and definitions are hard, notes that bans can make the banned thing more alluring — the host cites Australia, where he says 63–64% of banned kids simply used VPNs — and says he would rather fund scientifically grounded tools for young people and better platform design than legislate.
- He explains why social media research is contested: much of it is correlational, depressed kids may seek out social media rather than the reverse, and he proposes rigorous designs such as randomizing kids to different daily time limits and comparing depression scores a year later.
- On “touch grass,” he says he means getting back into reality — time with family and kids — instead of chasing phantoms online.
- On SSRIs, he notes the drugs were validated in randomized trials lasting only a few weeks or months, yet people are put on them for years, and that with only some 20–30% of patients responding positively (a figure the host cites and he works with), many doctors have made recommendations that didn’t help and may have hurt.
- Pressed on post-SSRI sexual dysfunction (PSSD), he calls it “a very real thing,” says the National Institute of Mental Health is interested in it and in deprescribing research, and tells the host and his girlfriend — Lauren Friedman, who spoke at the NIH’s mental health and overmedicalization summit — that NIH is investing in answers, though he cannot promise when they will come.
- He discusses how the existence of a pill shapes diagnosis itself, and invokes psychiatry’s history — lobotomy won a Nobel Prize and is now seen as barbaric — and the opioid crisis as warnings about medicine attaching itself to fads backed by moneyed interests.
- Asked about the serotonin theory of depression, citing Joanna Moncrieff’s umbrella review, he says depression is far too complex a phenomenon to reduce to synaptic chemistry alone.
- Closing with a message to young people, he says NIH is prioritizing understudied problems affecting them — autism, which he notes now affects 1 in 31 US children by diagnosis; better answers on who SSRIs help and how to manage their side effects; and addiction — and argues the remedy for frustration with medicine is more rigorous, honestly delivered science.